Charles was Chief Executive Officer, Volastra at Volastra Therapeutics, and Chief Medical Officer at Allergan. Charles Hugh-Jones joined Fresenius SE in 2026.
Charles Hugh-Jones is currently
Create your alert
to follow the career of Charles Hugh-Jones.
Do you need to know more about Charles Hugh-Jones? More results.
Report an error
Update the org chart details of Charles Hugh-Jones.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.